Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleTOXICOLOGY

Effect of Methoxychlor Administration to Male Rats on Hepatic, Microsomal Iodothyronine 5′-Deiodinase, Form I

Shana L. Morrell, James A. Fuchs and Jordan L. Holtzman
Journal of Pharmacology and Experimental Therapeutics July 2000, 294 (1) 308-312;
Shana L. Morrell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James A. Fuchs
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jordan L. Holtzman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

We previously reported that methoxychlor administration inhibits the activity of the hepatic, microsomal iodothyronine 5′-deiodinase, form I (ID-I; Zhou et al., 1995). Our data further suggested that the inhibition was due to the covalent binding of a methoxychlor metabolite to a 56-kDa protein identified as ID-I (Boado et al., 1988; Santini et al., 1992). This protein is 98% homologous to the thiol:protein disulfide oxidoreductase, form Q5 (ERp55; Boado et al., 1988; Santini et al., 1992). Although at the time there was some controversy, most studies now suggest that ID-I is actually catalyzed by a 27-kDa selenoprotein that does not form adducts with methoxychlor (Schoenmakers et al., 1989; Mandel et al., 1992; Zhou et al., 1995). Because the 27-kDa protein is considered to be ID-I instead of ERp55, we have further examined the basis for the decreased ID-I activity observed after methoxychlor administration. Male, 150- to 200-g Sprague-Dawley rats were given methoxychlor (0–100 mg/kg/day) in corn oil by gavage for 14 days. ID-I was determined by a thyronine-specific immunoassay. Treated rats showed a significant 15% decline in total hepatic, microsomal protein at all doses. The ID-I-specific activity showed a linear decrease with increasing log doses of methoxychlor. The maximum decrease was 42% at 100 mg/kg/day. The 27-kDa protein specific content declined 37%. In rats given methoxychlor the ratios of the 27-kDa protein mRNA to the 18S ribosomal RNA declined from 2.2 ± 0.27 × 10−3 (controls) to 0.99 ± 0.09 × 10−3 (100 mg/kg/day). These data suggest that the decreased ID-I observed with chronic methoxychlor administration was due to decreased transcription or stability of the mRNA encoding the 27-kDa protein.

Footnotes

  • Send reprint requests to: Jordan L. Holtzman, M.D., Ph.D., Chief, Section on Therapeutics (111T), Veterans Administration Medical Center, One Veterans Dr., Minneapolis, MN 55417. E-mail:holtz003{at}maroon.tc.umn.edu

  • ↵1 This study was supported in part by the General Medical Research Service of the Department of Veterans Affairs and by U.S. Public Health Service Grant ES 03731.

  • Abbreviations:
    T4
    thyroxine
    T3
    thyronine
    ID-I–III
    iodothyronine 5′-deiodinase, forms I–III
    ERp55
    same as TPDO-Q5
    PDI
    protein disulfide isomerase (also known as as ERp55 and TPDO-Q5)
    TPDO-Q5
    thiol:protein disulfide oxidoreductase, form Q5 (also known as ERp57, ERp60, ERp61, and GRP58)
    BrAcT3
    n-bromoacetyl-3,3′5-triiodothyronine
    PEG
    polyethylene glycol 6000
    DTT
    dithiothreitol
    SSC
    standard saline citrate
    • Received October 19, 1999.
    • Accepted April 3, 2000.
  • U.S. Government
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 294 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 294, Issue 1
1 Jul 2000
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Effect of Methoxychlor Administration to Male Rats on Hepatic, Microsomal Iodothyronine 5′-Deiodinase, Form I
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleTOXICOLOGY

Effect of Methoxychlor Administration to Male Rats on Hepatic, Microsomal Iodothyronine 5′-Deiodinase, Form I

Shana L. Morrell, James A. Fuchs and Jordan L. Holtzman
Journal of Pharmacology and Experimental Therapeutics July 1, 2000, 294 (1) 308-312;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleTOXICOLOGY

Effect of Methoxychlor Administration to Male Rats on Hepatic, Microsomal Iodothyronine 5′-Deiodinase, Form I

Shana L. Morrell, James A. Fuchs and Jordan L. Holtzman
Journal of Pharmacology and Experimental Therapeutics July 1, 2000, 294 (1) 308-312;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Experimental Procedures
    • Results
    • Discussion
    • Acknowledgment
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Tolerability profile of a GalNAc3-conjugated ASO in Monkeys
  • Preclinical Safety of Lung Instillation of Thyroid Hormone
  • Nefazodone Inhibits Anaerobic Glycolysis
Show more Toxicology

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics